Serina Therapeutics, Inc. (SER) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 26.47M | 6.08M | 11.5M | 7.99M | 5.75M | 5.68M | 5.42M | 8.92M | 8.94M | 7.62M | 1.14M | 1.35M |
| Cash & Short-Term Investments | 24.53M | 4.78M | 8.62M | 6.04M | 4.27M | 3.67M | 3.19M | 6.06M | 8.71M | 7.62M | 397K | 261K |
| Cash Only | 24.53M | 3.06M | 8.62M | 6.04M | 4.27M | 3.67M | 3.19M | 6.06M | 8.71M | 7.62M | 397K | 261K |
| Short-Term Investments | 0 | 1.72M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 14K | 51K | 65K | 0 | 71K | 6K |
| Days Sales Outstanding | - | - | - | - | - | - | 213.57 | - | 1.18K | - | 122.14 | 78 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 333K | 309K | 1.89M | 177K | 150K | 77K | 143K | 2K | 166K | 0 | 673K | 1.08M |
| Total Non-Current Assets | 825K | 871K | 916K | 950K | 977K | 1.05M | 2.01M | 1.79M | 1.92M | 1.35M | 11.07M | 10.93M |
| Property, Plant & Equipment | 800K | 842K | 892K | 950K | 977K | 1.05M | 1.12M | 1.2M | 1.29M | 1.35M | 0 | 0 |
| Fixed Asset Turnover | - | - | - | 0.13x | - | -0.01x | 0.01x | - | 0.00x | 2.29x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 509K | 541K | 574K | 0 | 640K | 673K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 50K | 50K | 50K | 0 | 10.43M | 10.25M |
| Other Non-Current Assets | 25K | 29K | 24K | 0 | 0 | 0 | 333K | 0 | 50K | 0 | 0 | 0 |
| Total Assets | 27.3M | 6.95M | 12.41M | 8.94M | 6.73M | 6.72M | 7.43M | 10.71M | 10.86M | 8.97M | 12.21M | 12.28M |
| Asset Turnover | - | - | - | 0.02x | - | -0.00x | 0.00x | - | 0.00x | 0.29x | 0.00x | 0.00x |
| Asset Growth % | 305.57% | 3.38% | 66.95% | -16.5% | -38% | -25.02% | -39.11% | -12.78% | -13.37% | 176.7% | 508.07% | 376.04% |
| Total Current Liabilities | 6.34M | 3.56M | 8.79M | 3.56M | 2.35M | 2.37M | 13.51M | 12.63M | 14.06M | 1.41M | 3.2M | 24.5M |
| Accounts Payable | 2.83M | 1.93M | 2.73M | 1.71M | 1.19M | 744K | 1.7M | 1.2M | 2.6M | 580K | 1.17M | 506K |
| Days Payables Outstanding | 11.89K | - | - | 8.23K | - | - | - | - | 5.8K | 13.43K | 1.46K | 3.07K |
| Short-Term Debt | 0 | 0 | 3.05M | 0 | 0 | 0 | 10.46M | 10.66M | 9.98M | 0 | 1.53M | 22.94M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.64M | 1.24M | 2.39M | 1.07M | 595K | 1.06M | 1M | 114K | -51K | 570K | 506K | 857K |
| Current Ratio | 4.18x | 1.71x | 1.31x | 2.24x | 2.45x | 2.40x | 0.40x | 0.71x | 0.64x | 5.39x | 0.36x | 0.06x |
| Quick Ratio | 4.18x | 1.71x | 1.31x | 2.24x | 2.45x | 2.40x | 0.40x | 0.71x | 0.64x | 5.39x | 0.36x | 0.06x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.33M | 3.42M | 2.03M | 3.73M | 2.82M | 3.85M | 7.75M | 14.47M | 1.11M | 3.44M | 693K | 10.07M |
| Long-Term Debt | 3.01M | 2.95M | 0 | 0 | 0 | 0 | 693K | 693K | 693K | 2.98M | 693K | 10.07M |
| Capital Lease Obligations | 159K | 196K | 148K | 185K | 227K | 268K | 312K | 362K | 413K | 462K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 162K | 283K | 1.88M | 3.55M | 2.59M | 3.58M | 6.74M | 13.41M | 0 | 0 | 0 | 0 |
| Total Liabilities | 9.67M | 6.99M | 10.82M | 7.29M | 5.17M | 6.22M | 21.26M | 27.1M | 15.16M | 4.86M | 3.9M | 34.57M |
| Total Debt | 3.17M | 3.14M | 3.2M | 185K | 227K | 268K | 11.47M | 11.92M | 11.31M | 3.69M | 2.22M | 33.01M |
| Net Debt | -21.36M | 86K | -5.42M | -5.86M | -4.04M | -3.4M | 8.28M | 5.86M | 2.61M | -3.92M | 1.82M | 32.75M |
| Debt / Equity | 0.18x | - | 2.01x | 0.11x | 0.15x | 0.53x | - | - | - | 0.90x | 0.27x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | 14.96x | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -15.89x | - | - |
| Interest Coverage | -33.23x | -15.76x | -764.83x | -717.00x | - | -160.88x | 87.44x | 22.39x | -149.79x | 6.97x | 18.52x | 8.48x |
| Total Equity | 17.63M | -37K | 1.59M | 1.65M | 1.56M | 508K | -13.83M | -16.39M | -4.31M | 4.11M | 8.31M | -22.3M |
| Equity Growth % | 1030.72% | -107.28% | 111.53% | 110.04% | 136.18% | -87.64% | -266.34% | 26.48% | 78.46% | 123.74% | 154.87% | -68.12% |
| Book Value per Share | 1.46 | -0.00 | 0.15 | 0.16 | 0.16 | 0.05 | -1.29 | -1.61 | -1.54 | 3.81 | 1.10 | -20.66 |
| Total Shareholders' Equity | 17.63M | -37K | 1.76M | 1.8M | 1.7M | 641K | -13.77M | -16.36M | -4.31M | 4.11M | 8.42M | -22.18M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 0 | 4K | 4K |
| Retained Earnings | -70.4M | -63.5M | -60.16M | -55.58M | -49.13M | -44.32M | -21.77M | -23.18M | -5.43M | -33.18M | -127.56M | -122.16M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -8K | -14K | -4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4K | 0 |
| Minority Interest | 0 | 0 | -166K | -156K | -142K | -133K | -54K | -30K | 0 | 0 | -109K | -121K |